|
|
Volumn 24, Issue 32, 2006, Pages 5176-5177
|
|
OPTIMOX1 in advanced colorectal cancer: Lack of evidence for a stop-and-go strategy [9]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
ANTINEOPLASTIC AGENT;
FOLFOX PROTOCOL;
PLATINUM COMPLEX;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
COLORECTAL CANCER;
COMBINATION CHEMOTHERAPY;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
DRUG RESPONSE;
HUMAN;
LETTER;
MUCOSA INFLAMMATION;
NAUSEA AND VOMITING;
NEUROPATHY;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
COLORECTAL TUMOR;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
DRUG PULSE THERAPY;
METASTASIS;
NOTE;
PATHOLOGY;
SAMPLE SIZE;
STATISTICAL ANALYSIS;
SURVIVAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DATA INTERPRETATION, STATISTICAL;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
NEOPLASM METASTASIS;
ORGANOPLATINUM COMPOUNDS;
PULSE THERAPY, DRUG;
SAMPLE SIZE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 34247188524
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.07.5630 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
